Bafna Pharmaceuticals (BAFNAPH) Shareholding Pattern

NSE: BAFNAPH • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 75.00%
FII Holding 9.34%
DII Holding 0.00%
Public Holding 12.13%
Total Shareholders 7,119
As of Dec 2025
View the latest shareholding pattern of Bafna Pharmaceuticals (BAFNAPH) including promoter, FII, DII, and public holdings. Track BAFNAPH ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See Bafna Pharmaceuticals dividend payments)

Bafna Pharmaceuticals (BAFNAPH) Shareholding Summary

  • Promoter holding remains unchanged at 75.00% in Dec 2025
  • FII/FPI holding remains unchanged at 9.34% in Dec 2025
  • DII holding remains unchanged at 0.00% in Dec 2025
  • Public holding has increased from 12.03% to 12.13% in Dec 2025
  • Number of shareholders decreased from 7,572 to 7,119 in Dec 2025

BAFNAPH Quarterly Ownership Changes

Quarter-over-quarter changes for Bafna Pharmaceuticals from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
No Change
DII Holding Change
Sept 2025 to Dec 2025
No Change
Public Holding Change
Sept 2025 to Dec 2025
+0.1%

Bafna Pharmaceuticals (BAFNAPH) Quarterly Shareholding Trends

Visual breakdown of BAFNAPH ownership distribution over time. Learn more about BAFNAPH price movement history.

Promoter
FII
DII
Public
Government

Rising institutional holdings in BAFNAPH often correlate with improved fundamentals. Check out BAFNAPH investment value.

Bafna Pharmaceuticals (BAFNAPH) Shareholding Data

Download complete BAFNAPH ownership data for offline analysis. Discover BAFNAPH fair value.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 75.00% 9.34% 0.00% 0.00% 12.13% 3.53% 100.00% 7,119
Sept 2025 75.00% 9.34% 0.00% 0.00% 12.03% 3.63% 100.00% 7,572
Jun 2025 75.00% 9.34% 0.00% 0.00% 11.62% 4.04% 100.00% 7,283
Mar 2025 75.00% 8.53% 0.00% 0.00% 11.06% 5.40% 99.99% 7,142
Dec 2024 88.30% 0.00% 0.00% 0.00% 7.66% 4.04% 100.00% 7,214
Sept 2024 88.30% 0.00% 0.00% 0.00% 7.69% 4.01% 100.00% 7,295
Jun 2024 88.30% 0.00% 0.00% 0.00% 7.37% 4.34% 100.01% 7,391
Mar 2024 88.30% 0.00% 0.00% 0.00% 7.48% 4.23% 100.01% 7,539
Dec 2023 88.43% 0.00% 0.00% 0.00% 7.66% 3.91% 100.00% 7,367
Sept 2023 88.74% 0.00% 0.00% 0.00% 6.87% 4.39% 100.00% 7,354
Jun 2023 90.00% 0.00% 0.00% 0.00% 5.64% 4.36% 100.00% 6,992
Mar 2023 90.00% 0.00% 0.00% 0.00% 5.64% 4.37% 100.01% 7,120
Dec 2022 90.02% 0.00% 0.00% 0.00% 5.61% 4.37% 100.00% 7,199
Sept 2022 90.00% 0.00% 0.00% 0.00% 5.62% 4.38% 100.00% 7,275
Jun 2022 90.12% 0.00% 0.00% 0.00% 5.50% 4.38% 100.00% 7,223
Mar 2022 90.42% 0.00% 0.00% 0.00% 5.24% 4.33% 99.99% 7,326
Dec 2021 90.42% 0.00% 0.00% 0.00% 6.10% 3.49% 100.01% 7,910
Sept 2021 90.40% 0.00% 0.00% 0.00% 6.26% 3.34% 100.00% 8,068
Jun 2021 90.39% 0.00% 0.00% 0.00% 6.23% 3.37% 99.99% 8,330
Mar 2021 91.74% 0.00% 0.00% 0.00% 6.31% 1.95% 100.00% 8,603

BAFNAPH promoter holding above 50% indicates strong insider confidence. Explore the BAFNAPH Q4 results for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 75.00% 9.34% 0.00% 0.00% 12.13% 3.53% 100.00% 7,119
Sept 2025 75.00% 9.34% 0.00% 0.00% 12.03% 3.63% 100.00% 7,572
Jun 2025 75.00% 9.34% 0.00% 0.00% 11.62% 4.04% 100.00% 7,283
Mar 2025 75.00% 8.53% 0.00% 0.00% 11.06% 5.40% 99.99% 7,142
Dec 2024 88.30% 0.00% 0.00% 0.00% 7.66% 4.04% 100.00% 7,214
Sept 2024 88.30% 0.00% 0.00% 0.00% 7.69% 4.01% 100.00% 7,295
Jun 2024 88.30% 0.00% 0.00% 0.00% 7.37% 4.34% 100.01% 7,391
Mar 2024 88.30% 0.00% 0.00% 0.00% 7.48% 4.23% 100.01% 7,539
Dec 2023 88.43% 0.00% 0.00% 0.00% 7.66% 3.91% 100.00% 7,367
Sept 2023 88.74% 0.00% 0.00% 0.00% 6.87% 4.39% 100.00% 7,354
Jun 2023 90.00% 0.00% 0.00% 0.00% 5.64% 4.36% 100.00% 6,992
Mar 2023 90.00% 0.00% 0.00% 0.00% 5.64% 4.37% 100.01% 7,120

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 75.00% 9.34% 0.00% 0.00% 12.13% 3.53% 100.00% 7,119
Dec 2024 88.30% 0.00% 0.00% 0.00% 7.66% 4.04% 100.00% 7,214
Dec 2023 88.43% 0.00% 0.00% 0.00% 7.66% 3.91% 100.00% 7,367
Dec 2022 90.02% 0.00% 0.00% 0.00% 5.61% 4.37% 100.00% 7,199
Dec 2021 90.42% 0.00% 0.00% 0.00% 6.10% 3.49% 100.01% 7,910

Year-over-year trends reveal long-term ownership shifts.

Understanding Bafna Pharmaceuticals (BAFNAPH) Shareholding Pattern

Bafna Pharmaceuticals shareholding pattern reveals who owns BAFNAPH stock and how ownership changes over time. High promoter stakes in BAFNAPH often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your BAFNAPH trades. Bafna Pharmaceuticals P/B valuation

Combine BAFNAPH ownership analysis with price movements and financial performance for a complete investment picture. (See BAFNAPH company valuation)